Posted by Michael Wonder on 30 Jan 2018
Indicative 1 April 2018 prices - 2018 April cycle
30 January 2018 - Indicative 1 April 2018 prices resulting from the 2018 April cycle of price disclosure have now been published.
These indicative price disclosure related price changes are being made available in advance of the effective date to assist companies and other stakeholders. They will come into effect under the Act and the National Health (Pharmaceutical Benefits) Regulations 2017 and have already been announced publicly.
